Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Polymers|June 5, 2020
Characterization and Therapeutic Effect of a pH Stimuli Responsive Polymeric Nanoformulation for Controlled Drug ReleaseMaria Victoria Cano-Cortes, Jose Antonio Laz-Ruiz, Juan Jose Diaz-Mochon, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|June 4, 2015
Infectious complications and mortality in an American acute care surgical serviceB R Bruns, M Lissauer, R Tesoriero, et al.
Oncology|February 23, 2016
Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover--The Case of Pazopanib in Advanced Renal Cell CarcinomaJose Diaz, Cora N Sternberg, Faisal Mehmud, et al.
Experimental Dermatology|March 18, 2015
The HPV16 E6 oncoprotein and UVB irradiation inhibit the tumor suppressor TGFβ pathway in the epidermis of the K14E6 transgenic mouseMarco Popoca-Cuaya, Jose Diaz-Chavez, Jesus Hernandez-Monge, et al.
Journal of Pediatric Surgery|August 16, 2022
Variation in cost of disposable operating room supplies at a children's hospitalShannon N Acker, Jill L Kaar, Connor Prendergast, et al.
International Journal of Molecular Sciences|September 14, 2024
Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican PatientsMyrna Candelaria, Dennis Cerrato-Izaguirre, Olga Gutierrez, et al.
Molecular & Cellular Proteomics : MCP|June 9, 2006
Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkersRichard R Drake, E Ellen Schwegler, Gunjan Malik, et al.
Computers in Biology and Medicine|May 9, 2022
Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugsNeda Eskandarzade, Abozar Ghorbani, Samira Samarfard, et al.
Surgery|August 9, 2016
Delayed interventions and mortality in trauma damage control laparotomyMargaret H Lauerman, Joseph Dubose, Kyle Cunningham, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2020
Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drugMandy Juarez, Alejandro Schcolnik-Cabrera, Guadalupe Dominguez-Gomez, et al.
Pageof 21